本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

TriSalus Life Sciences Inc.

5.51
+0.32006.17%
盘后5.510.00000.00%16:04 EDT
成交量:2.79万
成交额:15.23万
市值:2.08亿
市盈率:-4.84
高:5.58
开:5.22
低:5.22
收:5.19
数据加载中...
2024/04/16

重要事件披露

Form 8-K - Current report
2024/04/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/12

重要事件披露

Form 8-K - Current report
2024/01/25

重要事件披露

Form 8-K - Current report
2024/01/05

重要事件披露

Form 8-K - Current report
2023/12/21

SEC问询函

Form CORRESP - Correspondence
2023/12/21

SEC问询函

Form CORRESP - Correspondence
2023/12/15

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/12/15

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/14

SEC问询函

Form CORRESP - Correspondence
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/10/19

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/10/18

SEC问询函

Form CORRESP - Correspondence
2023/10/16

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/10/03

重要事件披露

Form 8-K - Current report
2023/09/02

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/09/01

重要事件披露

Form 8-K - Current report